SEC 13F Intelligence

Farallon Capital Management, L.L.C. / ABBV

Farallon Capital Management, L.L.C.’s Abbvie Inc Position

Does Farallon Capital Management, L.L.C. own Abbvie Inc (ABBV)? Not currently — the last reported position was 939.2K shares worth $152M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$152M
Q4 2022
Shares
939.2K
% of Portfolio
+0.99%
Quarters Held
12
position exited

Position History ABBV

Reported value by quarter
Q3 ’19: $76MQ3 ’19Q4 ’19: $221MQ1 ’20: $305MQ1 ’20Q2 ’20: $407MQ3 ’20: $372MQ3 ’20Q4 ’20: $123MQ3 ’21: $52MQ3 ’21Q4 ’21: $218MQ1 ’22: $186MQ1 ’22Q2 ’22: $77MQ3 ’22: $97MQ3 ’22Q4 ’22: $152Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2022939.2K$152M+0.99%
Q3 2022725.1K$97M+0.53%
Q2 2022505.5K$77M+0.44%
Q1 20221.14M$186M+0.82%
Q4 20211.61M$218M+1.13%
Q3 2021481.8K$52M+0.25%
Q4 20201.15M$123M+0.79%
Q3 20204.25M$372M+2.60%
Q2 20204.15M$407M+3.30%
Q1 20204.00M$305M+1.88%
Q4 20192.50M$221M+1.78%
Q3 20191.00M$76M+0.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of ABBV.